Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

SS-LUP-332 Muscle Performance Results: Research vs Commercial Product Comparison

Purity Verification ≥98% via HPLC-MS, batch-specific COA Variable, often unverified N/A Research reproducibility demands verified purity. Uncharacterized compounds introduce uncontrolled variables that invalidate timeline data Timeline to Detectable Gene Expre

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Purity Verification
  • ≥98% via HPLC-MS, batch-specific COA
  • Variable, often unverified
  • N/A
  • Research reproducibility demands verified purity. Uncharacterized compounds introduce uncontrolled variables that invalidate timeline data
  • Timeline to Detectable Gene Expression
  • 48–72 hours (PGC-1α mRNA)
  • Inconsistent due to purity variance
  • 7–14 days (training-induced)
  • Compound purity directly affects receptor binding efficiency. Impure samples may delay or attenuate initial molecular response
  • Timeline to Functional Performance Gain
  • 4–8 weeks (time-to-exhaustion)
  • 6–12 weeks (if effective)
  • 8–12 weeks
  • SS-LUP-332 compresses the adaptation timeline vs training alone, but only when dosing consistency and purity are controlled
  • Mechanism of Action
  • Direct ERRγ agonism → PGC-1α → mitochondrial biogenesis
  • Same if pure; unknown if contaminated
  • AMPK activation → PGC-1α (indirect)
  • Training stimulates overlapping pathways but requires accumulated workload; SS-LUP-332 bypasses the training stimulus requirement
  • Applicability to Sedentary Models
  • High. 70–100% endurance gain without training
  • Potentially high if pure
  • Moderate. Requires training adherence
  • The sedentary-model response is SS-LUP-332's most compelling finding and most sensitive to compound quality